Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

被引：127

作者：

Cascinu, S. ^{[1
]}

Falconi, M. ^{[2
]}

Valentini, V. ^{[3
]}

Jelic, S. ^{[4
]}

机构：

[1] Univ Politecn Marche, Dept Med Oncol, Ancona, Italy

[2] Univ Verona, Dept Surg & Gastroenterol, I-37100 Verona, Italy

[3] Univ Cattolica Sacro Cuore, Dept Radiotherapy, Rome, Italy

[4] Inst Oncol & Radiol, Internal Med Serv, Belgrade, Serbia

来源：

ANNALS OF ONCOLOGY | 2010年 / 21卷

关键词：

PHASE-III TRIAL; GEMCITABINE; CHEMORADIOTHERAPY; ADENOCARCINOMA; CHEMOTHERAPY; METAANALYSIS; RESECTION; CHEMORADIATION;

D O I：

10.1093/annonc/mdq165

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：v55 / v58

页数：4

共 27 条

[1] Advances in counselling and surveillance patients at risk for pancreatic cancer [J].

Brand, Randall E. ;

Lerch, Markus M. ;

Rubinstein, Wendy S. ;

Neoptolemos, John P. ;

Whitcomb, David C. ;

Hruban, Ralph H. ;

Brentnall, Teresa A. ;

Lynch, Henry T. ;

Canto, Marcia I. .

GUT, 2007, 56 (10) :1460-1469

[2]

Brune K, 2006, AM J SURG PATHOL, V30, P1067

[3]

Canto Marcia Irene, 2008, Gastrointest Endosc Clin N Am, V18, P535, DOI 10.1016/j.giec.2008.05.012

[4] The role of staging laparoscopy for intraabdominal cancers: an evidence-based review [J].

Chang, L. ;

Stefanidis, D. ;

Richardson, W. S. ;

Earle, D. B. ;

Fanelli, R. D. .

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2009, 23 (02) :231-241

[5] Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer.: Definitive results of the 2000-01 FFCD/SFRO study [J].

Chauffert, B. ;

Mornex, F. ;

Bonnetain, F. ;

Rougier, P. ;

Mariette, C. ;

Bouche, O. ;

Bosset, J. F. ;

Aparicio, T. ;

Mineur, L. ;

Azzedine, A. ;

Hammel, P. ;

Butel, J. ;

Stremsdoerfer, N. ;

Maingon, P. ;

Bedenne, L. .

ANNALS OF ONCOLOGY, 2008, 19 (09) :1592-1599

[6]

Colucci G, 2009, J CLIN ONCOL, V27

[7] Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head [J].

Evans, Douglas B. ;

Varadhachary, Gauri R. ;

Crane, Christopher H. ;

Sun, Charlotte C. ;

Lee, Jeffrey E. ;

Pisters, Peter W. T. ;

Vauthey, Jean-Nicolas ;

Wang, Huamin ;

Cleary, Karen R. ;

Staerkel, Gregg A. ;

Charnsangavej, Chusilp ;

Lano, Elizabeth A. ;

Ho, Linus ;

Lenzi, Renato ;

Abbruzzese, James L. ;

Wolff, Robert A. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) :3496-3502

[8] Estimates of the cancer incidence and mortality in Europe in 2006 [J].

Ferlay, J. ;

Autier, P. ;

Boniol, M. ;

Heanue, M. ;

Colombet, M. ;

Boyle, P. .

ANNALS OF ONCOLOGY, 2007, 18 (03) :581-592

[9] Meta-analysis of randomized trials: Evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer [J].

Heinemann, Volker ;

Boeck, Stefan ;

Hinke, Axel ;

Labianca, Roberto ;

Louvet, Christophe .

BMC CANCER, 2008, 8 (1)

[10] Systematic review and meta-analysis of prophylactic gastroenterostomy for unresectable advanced pancreatic cancer [J].

Hueser, N. ;

Michalski, C. W. ;

Schuster, T. ;

Friess, H. ;

Kleeff, J. .

BRITISH JOURNAL OF SURGERY, 2009, 96 (07) :711-719

← 1 2 3 →